Huminsulin 30/70 Suspension for Injection 100IU/ml

HUMINSULIN 30/70 Suspension for Injection 100 IU/ml – Premixed Human Insulin for Diabetes Management

HUMINSULIN 30/70 Suspension for Injection 100 IU/ml is a prescription premixed human insulin used to help control blood glucose levels in people with diabetes mellitus. It contains 30% soluble or regular human insulin for relatively faster action and 70% isophane or NPH human insulin for a longer-lasting effect. This fixed-ratio formulation helps manage the rise in blood glucose around meals while providing continued insulin activity between meals. It works by helping glucose move from the bloodstream into muscle and fat cells and by reducing excess glucose production in the liver. The insulin dose and injection schedule must be individualized by a qualified healthcare professional according to blood glucose readings, meal pattern, physical activity, medical condition, and response to treatment.

Key Features

• Premixed Human Insulin: Combines short-acting and intermediate-acting human insulin.
• 30/70 Formulation: Contains 30% soluble human insulin and 70% isophane human insulin.
• 100 IU/ml Strength: Each millilitre contains 100 international units of human insulin.
• Supports Blood Glucose Control: Provides mealtime and continued background insulin activity.
• Subcutaneous Administration: Injected beneath the skin as directed by a healthcare professional.
• Prescription Medicine: Requires regular blood glucose monitoring and medical supervision.

Active Ingredients

• Soluble Human Insulin 30%: Provides the relatively faster-acting component of the formulation.
• Isophane Human Insulin 70%: Also known as NPH insulin, providing the intermediate-acting component.

Uses

• Management of diabetes mellitus requiring insulin treatment.
• Blood glucose control in eligible patients with type 1 diabetes.
• Blood glucose control in eligible patients with type 2 diabetes.
• Use as part of an individualized diabetes plan involving diet, physical activity, and glucose monitoring.

How to Prepare

• Check the insulin name, 30/70 ratio, strength, and expiry date before every injection.
• Gently roll and invert the container according to the supplied instructions until the suspension appears uniformly white and cloudy.
• Do not shake the insulin vigorously.
• Do not use it if the insulin does not become uniformly cloudy after mixing.
• Do not use it if particles, clumps, crystals, or unusual discoloration are visible.
• Use only a compatible U-100 insulin syringe or approved injection device suitable for the selected presentation.

How to Use

• Use HUMINSULIN 30/70 exactly in the dose prescribed by your healthcare professional.
• It is generally injected approximately 30–45 minutes before a meal, unless your doctor provides different instructions.
• Administer only as a subcutaneous injection into the abdomen, thigh, upper arm, or buttocks.
• Rotate injection sites within the selected body area with every dose.
• Do not inject into skin that is thickened, pitted, lumpy, bruised, scarred, or damaged.
• Do not inject it into a vein or use it in an insulin-infusion pump.
• Do not mix it with another insulin or diluent unless specifically directed by a healthcare professional.
• Do not change the dose, insulin type, or injection schedule without medical supervision.

Precautions

• Do not use HUMINSULIN 30/70 during an episode of low blood glucose.
• Monitor blood glucose regularly according to your prescribed diabetes-management plan.
• Inform your doctor if you have kidney disease, liver disease, low potassium levels, heart failure, or recurrent hypoglycaemia.
• Tell your healthcare provider about all diabetes medicines, prescription medicines, supplements, and herbal products you use.
• Changes in meals, physical activity, illness, body weight, alcohol intake, or other medicines may alter insulin requirements.
• Always carry a suitable source of fast-acting glucose as advised by your healthcare professional.
• Never share insulin syringes, cartridges, pens, or needles with another person.
• Use a new sterile needle or syringe for each injection.

Warning

• Hypoglycaemia: Low blood glucose is the most common adverse effect and may become severe or life-threatening.
• Symptoms may include sweating, shaking, hunger, headache, dizziness, confusion, blurred vision, weakness, seizures, or unconsciousness.
• Hyperglycaemia: Missed doses, insufficient insulin, illness, or incorrect administration may cause dangerously high blood glucose.
• Medication Errors: Confusing insulin types, strengths, or doses may cause severe blood glucose complications.
• Allergic Reactions: Seek urgent medical help for facial swelling, breathing difficulty, widespread rash, dizziness, or rapid heartbeat.
• Low Potassium: Insulin may reduce blood potassium levels in susceptible patients.
• Seek immediate medical assistance for severe hypoglycaemia, loss of consciousness, seizures, or symptoms of a serious allergic reaction.

Common Side Effects

• Low blood glucose.
• Injection-site redness, swelling, itching, or discomfort.
• Skin thickening, pits, or lumps at repeatedly used injection sites.
• Weight gain.
• Swelling caused by fluid retention.
• Skin rash or itching.

Storage

• Before first use, store in a refrigerator between 2°C and 8°C.
• Do not freeze or use the insulin if it has been frozen.
• Protect the product from excessive heat and direct light.
• Keep it in its original packaging until required.
• After opening or inserting a cartridge into a pen, follow the presentation-specific storage period printed on the original packaging.
• Do not use the insulin after the stated in-use period, even if some medicine remains.
• Keep out of reach of children.

Legal Disclaimer: HUMINSULIN 30/70 Suspension for Injection 100 IU/ml is a prescription insulin medicine intended for use under the supervision of a qualified healthcare professional. Incorrect dosing, delayed meals, or improper administration may cause severe hypoglycaemia or hyperglycaemia. This information is provided for educational purposes only and should not replace medical advice, diabetes training, blood glucose monitoring, or the instructions supplied with the medicine.